我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

评估急性心肌梗死患者短期内死亡风险的四种指标比较(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第1期
页码:
42-45
栏目:
临床研究
出版日期:
2012-02-25

文章信息/Info

Title:
Evaluation of prognosis of early mortality in patients with acute myocardial infarction
作者:
李昌义金 炜
(上海交通大学附属上海市第一人民医院心内科,上海 200080)
Author(s):
LI Chang-yi JIN Wei
(Department of Cardiology, Shanghai First People’s Hospital, Shanghai Jiaotong University, Shanghai 200080, China)
关键词:
心肌梗死急性第二代急性生理学及慢性健康状况评分全球急性冠状动脉事件注册风险评分游离三碘甲状腺原氨酸反三碘甲状腺原氨酸死亡风险
Keywords:
acute myocardial infarction APACHE II score GRACE score free triiodothyronine reverse triiodothyronine mortality
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:评价第二代急性生理学及慢性健康状况 (APACHE II)评分、全球急性冠状动脉事件注册(GRACE)风险评分、游离三碘甲状腺原氨酸(FT3)水平和反T3水平对急性心肌梗死(AMI)患者短期内死亡风险的预测价值。方法: 入选240例AMI患者,对其进行APACHE II评分、GRACE风险评分,检测其FT3水平和反T3水平。统计患者住院期间病死率,患者出院1个月后电话随访其生存情况。结果: 死亡患者的APACHE II评分、GRACE风险评分均高于存活患者(19.7±2.9 vs. 14.4±3.0,P<0.01;260±51 vs. 209±34,P<0.01),死亡患者与存活患者间的FT3水平、反T3水平差异有统计学意义[(3.6±1.2)pmol/L vs.(4.9±1.5)pmol/L,P<0.01;(1.4±0.3)nmol/L vs.(1.2±0.4)nmol/L,P<0.05]。Cox回归风险比例模型分析:APACHE II评分、GRACE风险评分和FT3水平是AMI患者短期内死亡的影响因素(HR=1.459,95%CI:1.227-1.734,P<0.01;HR=0.997, 95%CI:0.987-1.008,P<0.01;HR=0.6, 95%CI:0.418-0.862,P<0.01)。APACHE II评分标准偏回归系数大于GRACE评分和FT3水平的标准偏回归系数(1.321,0.611,-0.573)。受试者工作特征曲线(ROC)下面积(AUC)分析:APACHE II评分的AUC大于GRACE风险评分和反T3水平的AUC(0.893, 95%CI:0.834-0.952;0.822, 95%CI:0.757-0.866;0.681, 95%CI:0.590-0.771,P<0.01)。结论: APACHE II评分对AMI患者短期内死亡风险的预测价值高于GRACE风险评分、FT3水平和反T3水平。
Abstract:
AIM: To evaluate the performance of Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, Global Registry of Acute Coronary Events (GRACE) risk scores, free triiodothyronine (FT3) levels, and reverse T3 (rT3) levels in patients with acute myocardial infarction (AMI). METHODS: A total of 240 patients with AMI were enrolled. Blood samples were obtained for serum levels of FT3 and rT3 measurements at the time of admission. APACHE II scores and GRACE risk scores were calculated for each patient. Mortality during hospitalization was evaluated. Information regarding survival was obtained by telephone inquiry 1 month after discharge. RESULTS: APACHE II scores and GRACE risk scores were higher in nonsurvivors in comparison with survivors (19.7±2.9 vs. 14.4±3.0, 260±51 vs. 209±34, P<0.01). Significant differences in FT3 and rT3 levels were observed between nonsurvivors and survivors [(3.6±1.2) vs.(4.9±1.5) pmol/L, P<0.01 and (1.4±0.3) vs.(1.2±0.4) nmol/L, P<0.05]. In a multivariate Cox proportional hazards model, APACHE II scores, GRACE risk scores and FT3 levels were independent predictors of early mortality (HR=1.459, 95%CI: 1.227-1.734, P<0.01; HR=0.997, 95%CI: 0.987-1.008, P<0.01; HR=0.6, 95%CI: 0.418-0.862, P<0.01). Standard partial regression coefficient of APACHE II scores was higher than those of GRACE risk scores and FT3 levels (1.321, 0.611, -0.573). Area under the curve for APACHE II scores was higher than that for GRACE risk scores and rT3 levels (0.893, 95% CI: 0.834-0.952; 0.822, 95% CI: 0.757-0.866; 0.681, 95% CI: 0.590-0.771, P<0.01). CONCLUSIONS: APACHE II scores are of the highest value for mortality prediction in patients with AMI.

参考文献/References

[1]Yan AT,Yan RT,Tan M,et al.Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes[J].Arch Intern Med,2007,167(10):1009-1016.

[2]Morrow DA,Antman EM,Snapinn SM,et al.An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS[J].Eur Heart J,2002,23(3):223-229.

[3]Yan AT,Yan RT,Tan M,et al.In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score[J].Am J Cardiol,2005,96(7):913-916.

[4]Knaus WA,Draper EA,Wagner DP,et al.APACHE II:a severity of disease classification system[J].Crit Care Med,1985,13(10):818-829.

[5]Granger CB,Goldberg RJ,Dabbous O,et al.Predictors of hospital mortality in the global registry of acute coronary events[J].Arch Intern Med,2003,163(19):2345-2353.

[6]Iervasi G,Pingitore A,Landi P,et al.Low-T3 syndrome:a strong prognostic predictor of death in patients with heart disease[J].Circulation,2003,107(5):708-713.

[7]Friberg L,Drvota V,Bjelak AH,et al.Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction[J].Am J Med,2001,111(9):699-703.

[8]Eagle KA,Lim MJ,Dabbous OH,et al.A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry[J].JAMA,2004,291(22):2727-2733.

[9]Lichtman JH,Spertus JA,Reid KJ.Acute noncardiac conditions and in-hospital mortality in patients with acute myocardial infarction[J].Circulation,2007,116(17):1925-1930.

[10]Carrero JJ,Qureshi AR,Axelsson J,et al.Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease[J].J Intern Med,2007,262(6):690-701.

[11]Karadag F,Ozcan H,Karul AB,et al.Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease[J].Respir Med,2007,101(7):1439-1446.

[12]Pinelli M,Bindi M,Cassetti G,et al.Relationship between low T3 syndrome and NT-proBNP levels in non-cardiac patients[J].Acta Cardiol,2007,62(1):19-24.

备注/Memo

备注/Memo:
收稿日期:2011-09-23.通讯作者:金炜,主任医师,主要从事冠心病介入治疗的研究 Email:JW_8585@hotmail.com 作者简介:李昌义,硕士生 Email:lichangyi1212@sina.com
更新日期/Last Update: 2012-02-14